Brian is a managing director at Deloitte and has more than 18 years of experience within the Life Sciences Commercial Strategy space, having served most of the world’s largest life sciences clients in the areas of market access, pricing, commercial and launch strategy. He has dedicated his career to advancing new perspectives on the growing challenge of sustainable pricing, affordability, access, and value capture for traditional, specialty, oncology and increasingly transformative drug therapies in cell & gene therapy and rare diseases – having served over 250 unique products. Brian has a passion for leadership development, coaching and mentoring and has been recognized by PharmaVoice as a Top 100 "Most Inspiring Leader" in the Life Sciences Industry.
Value/Access/Pricing: An essential enabler for delivering on the promise of oncology innovation